These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Guo C, Liu QG, Yang W, Zhang ZL, Yao YM. Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495 [Abstract] [Full Text] [Related]
43. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate. Wang CT, Meng M, Zhang JC, Jin CJ, Jiang JJ, Ren HS, Jiang JM, Qin CY, Yu DQ. Chin Med J (Engl); 2008 Sep 05; 121(17):1707-11. PubMed ID: 19024104 [Abstract] [Full Text] [Related]
44. ING1a and ING1b different expressed in sporadic hepatocellular carcinoma. Chen X, Du J, Zhu T. Pathol Biol (Paris); 2009 May 05; 57(3):e17-21. PubMed ID: 18450387 [Abstract] [Full Text] [Related]
45. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Clin Cancer Res; 2009 Jul 15; 15(14):4686-93. PubMed ID: 19584149 [Abstract] [Full Text] [Related]
46. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Akiba J, Ogasawara S, Kawahara A, Nishida N, Sanada S, Moriya F, Kuwano M, Nakashima O, Yano H. Oncol Rep; 2008 Dec 15; 20(6):1329-35. PubMed ID: 19020710 [Abstract] [Full Text] [Related]
47. Amphiregulin: a new growth factor in hepatocarcinogenesis. Berasain C, Castillo J, Perugorría MJ, Prieto J, Avila MA. Cancer Lett; 2007 Aug 28; 254(1):30-41. PubMed ID: 17321672 [Abstract] [Full Text] [Related]
48. Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of metalloproteinase-1? Akalin I, Güllü IH, Kurdoglu M, Marangoz S. Med Hypotheses; 2001 Aug 28; 57(2):221-3. PubMed ID: 11461177 [Abstract] [Full Text] [Related]
49. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice. Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D. Mol Cancer Res; 2007 Nov 28; 5(11):1159-70. PubMed ID: 18025261 [Abstract] [Full Text] [Related]
50. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma. Miao X, Liu G, Xu X, Xie C, Sun F, Yang Y, Zhang T, Hua S, Fan W, Li Q, Huang S, Wang Q, Liu G, Zhong D. Cancer Genet Cytogenet; 2008 Oct 28; 186(1):25-32. PubMed ID: 18786439 [Abstract] [Full Text] [Related]
51. Investigation on the rheological properties of hepatocellular carcinoma cells and their relevance to cytoskeleton structure. Wu Z, Zhang G, Shao K, Long M, Wang H, Song G, Wang B, Cai S. Zhonghua Gan Zang Bing Za Zhi; 2001 Feb 28; 9(1):25-7. PubMed ID: 11242130 [Abstract] [Full Text] [Related]
52. Pleomorphism of cancer cells with the expression of plectin and concept of filament bundles in human hepatocellular carcinoma. Liu YH, Ho CC, Cheng CC, Pei RJ, Hsu YH, Yeh KT, Tsai MC, Lai YS. Res Commun Mol Pathol Pharmacol; 2001 Feb 28; 120-121(1-6):43-54. PubMed ID: 21469503 [Abstract] [Full Text] [Related]
53. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell. Gong J, Wang J, Ren K, Liu C, Li B, Shi Y. J Surg Res; 2009 May 01; 153(1):17-22. PubMed ID: 18675992 [Abstract] [Full Text] [Related]
54. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Baumhoer D, Tornillo L, Stadlmann S, Roncalli M, Diamantis EK, Terracciano LM. Am J Clin Pathol; 2008 Jun 01; 129(6):899-906. PubMed ID: 18480006 [Abstract] [Full Text] [Related]
55. Hepatocarcinogenesis in non-cirrhotic liver is associated with a reduced number of clonal hepatocellular patches in non-tumorous liver parenchyma. Adam AC, Faudou V, Paschen SA, Adam OM, Kahl P, Drebber U, Fischer HP, Büttner R. J Pathol; 2012 Nov 01; 228(3):333-40. PubMed ID: 22685011 [Abstract] [Full Text] [Related]
56. [Expression and significance of minichromosome maintenance protein7 in hepatocellular carcinoma]. Liu J, Yao SK, Yin F. Zhonghua Gan Zang Bing Za Zhi; 2008 Jan 01; 16(1):55-6. PubMed ID: 18226346 [No Abstract] [Full Text] [Related]
58. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression. Lu X, Feng X, Man X, Yang G, Tang L, Du D, Zhang F, Yuan H, Huang Q, Zhang Z, Liu Y, Strand D, Chen Z. Clin Cancer Res; 2009 May 15; 15(10):3287-96. PubMed ID: 19447873 [Abstract] [Full Text] [Related]
59. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma. Zhao WB, Li Y, Liu X, Zhang LY, Wang X. Int J Mol Med; 2008 Aug 15; 22(2):187-92. PubMed ID: 18636172 [Abstract] [Full Text] [Related]
60. HCC CKs are altered histones during tumor transformation in hepatoma. Liu YH, Pei RJ, Cheng CC, Ho HC, Ho CC, Yeh KT, Lee KY, Lai YS. Res Commun Mol Pathol Pharmacol; 2002 Aug 15; 112(1-4):27-38. PubMed ID: 15080494 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]